BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24692575)

  • 1. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
    Sanner H; Sjaastad I; Flatø B
    Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
    Sanner H; Gran JT; Sjaastad I; Flatø B
    Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
    Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
    Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
    Lazarevic D; Pistorio A; Palmisani E; Miettunen P; Ravelli A; Pilkington C; Wulffraat NM; Malattia C; Garay SM; Hofer M; Quartier P; Dolezalova P; Penades IC; Ferriani VP; Ganser G; Kasapcopur O; Melo-Gomes JA; Reed AM; Wierzbowska M; Rider LG; Martini A; Ruperto N;
    Ann Rheum Dis; 2013 May; 72(5):686-93. PubMed ID: 22736096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.
    Mathiesen P; Hegaard H; Herlin T; Zak M; Pedersen FK; Nielsen S
    Scand J Rheumatol; 2012 Feb; 41(1):50-8. PubMed ID: 22044089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated.
    Almeida B; Campanilho-Marques R; Arnold K; Pilkington CA; Wedderburn LR; Nistala K;
    Arthritis Rheumatol; 2015 Sep; 67(9):2495-502. PubMed ID: 25988361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile dermatomyositis at a tertiary care hospital: is there any change in the last decade?
    Prasad S; Misra R; Agarwal V; Lawrence A; Aggarwal A
    Int J Rheum Dis; 2013 Oct; 16(5):556-60. PubMed ID: 24164843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.
    Schwartz T; Sanner H; Gjesdal O; Flatø B; Sjaastad I
    Ann Rheum Dis; 2014 Oct; 73(10):1805-10. PubMed ID: 23881732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
    Sharma A; Gupta A; Rawat A; Suri D; Singh S
    Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM).
    Brown VE; Pilkington CA; Feldman BM; Davidson JE;
    Rheumatology (Oxford); 2006 Aug; 45(8):990-3. PubMed ID: 16467366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
    Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK; Lindsley CB; Pilkington CA; Punaro M; Ravelli A; Reed AM; Rouster-Stevens K; van Royen-Kerkhof A; Dressler F; Magalhaes CS; Constantin T; Davidson JE; Magnusson B; Russo R; Villa L; Rinaldi M; Rockette H; Lachenbruch PA; Miller FW; Vencovsky J; Ruperto N;
    Arthritis Rheumatol; 2017 May; 69(5):911-923. PubMed ID: 28382778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case-control study.
    Sanner H; Kirkhus E; Merckoll E; Tollisen A; Røisland M; Lie BA; Taraldsrud E; Gran JT; Flatø B
    Arthritis Care Res (Hoboken); 2010 Aug; 62(8):1103-11. PubMed ID: 20506141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction.
    Schwartz T; Sjaastad I; Flatø B; Vistnes M; Christensen G; Sanner H
    Rheumatology (Oxford); 2014 Dec; 53(12):2214-22. PubMed ID: 24996906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease.
    Marstein H; Schwartz T; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
    Rheumatology (Oxford); 2020 Aug; 59(8):1862-1870. PubMed ID: 31740970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
    Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
    Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.
    Schmeling H; Stephens S; Goia C; Manlhiot C; Schneider R; Luthra S; Stringer E; Feldman BM
    Rheumatology (Oxford); 2011 May; 50(5):885-93. PubMed ID: 21156669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study.
    Okong'o LO; Esser M; Wilmshurst J; Scott C
    Pediatr Rheumatol Online J; 2016 Nov; 14(1):60. PubMed ID: 27835954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myositis disease activity tool in Chinese patients with polymyositis/dermatomyositis].
    Shu XM; Ma L; Lu X; Xie Y; Wang GC
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1328-30. PubMed ID: 21756759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The arthritis of inflammatory childhood myositis syndromes.
    Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
    J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.